Management of Hepatitis C Infection

  • Authors: Jordan J. Feld, MD, MPH; Hemant Shah, MD, MScCH HPTE (More Info)
  • Editor In Chief: Stefan Zeuzem, MD
  • Last Reviewed: 1/9/21 (What's New)

Summary

    Simplified Treatment: All Genotypes
    • Patients who have not received previous HCV treatment are eligible for simplified treatment
    Genotype 1 Patients
    • AASLD/IDSA guidelines recommend DAA-based regimens for genotype 1 HCV–infected patients according to subgenotype, presence of baseline NS5A resistance associated mutations, and cirrhosis status (Table 24) (Table 25) (Management Guidelines)[AASLD-IDSA HCV]
    Genotype 2 Patients
      Genotype 3 Patients
        Genotype 4, 5, 6 Patients

        Action required

        Keywords: Hepatitis C-Treatment

        ©2020 Clinical Care Options, LLC. All Rights Reserved.

        The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.